1. null
   Agnieszka Sobczak-Kupiec et al, 2017 CrossRef
2. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells
   Nan Zhang et al, 2017, Cancer Letters CrossRef
3. Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer
   Baokun Chen et al, 2017, J. Cell Commun. Signal. CrossRef
4. mi R -27b and mi R -34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
   Guangwei Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
5. AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells
   Zhenhong Ni et al, 2018, Autophagy CrossRef
6. Silencing of Long Non-coding RNA MIAT Sensitizes Lung Cancer Cells to Gefitinib by Epigenetically Regulating miR-34a
   Yunfeng Fu et al, 2018, Front. Pharmacol. CrossRef
7. Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells
   Jinhui Zhu et al, 2018, Biotechnology and Applied Biochemistry CrossRef
8. Human antigen R and drug resistance in tumors
   Fenghai Zhou et al, 2019, Invest New Drugs CrossRef
9. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis
   Urszula Wasik et al, 2017, Sci Rep CrossRef
10. Epigenetic Modifications of Autophagy in Cancer and Cancer Therapeutics
    Chandra S. Bhol et al, 2019, Seminars in Cancer Biology CrossRef
11. The emergence of noncoding RNAs as Heracles in autophagy
    Jian Zhang et al, 2017, Autophagy CrossRef
12. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
    Jian-Zhong Lin et al, 2020, Cancer Lett CrossRef
13. On ATG4B as Drug Target for Treatment of Solid Tumours—The Knowns and the Unknowns
    null Agrotis et al, 2019, Cells CrossRef
14. The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study
    Peter Tan et al, 2017, Oncotarget CrossRef
15. Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
    Rama Jayaraj et al, 2020, Cancers CrossRef
16. Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells
    Yao-Min Chen et al, 2016, Oncotarget CrossRef
17. Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
    Anthony Quagliano et al, 2020, Front. Oncol. CrossRef
18. Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment
    Priyanka Sharma et al, 2020, Front. Pharmacol. CrossRef
19. Implications of miRNAs on TGF-β/TAK1/mTOR pathway in mediating the renoprotective effects of pentoxifylline against cisplatin-induced nephrotoxicity in rats
    Hekmat M. El Magdoub et al, 2020, Toxicology and Applied Pharmacology CrossRef
20. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors.
    Susana Romero-Garcia et al, 2020, Front Oncol CrossRef
21. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
    Milad Ashrafizadeh et al, 2020, European Journal of Pharmacology CrossRef
22. The regulatory factors and pathological roles of autophagy‐related protein 4 in diverse diseases: Recent research advances
    Fan Xia et al, 2020, Med Res Rev CrossRef
23. Micro-RNAs in the regulation of autophagy and their possible use in age-related macular degeneration therapy
    Juha M.T. Hyttinen et al, 2021, Ageing Research Reviews CrossRef
24. Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation
    Masashi Ishikawa et al, 2021, BMC Anesthesiol CrossRef
25. Assessment of AXL and mTOR genes expression in medullary thyroid carcinoma (MTC) cell line in relation with over expression of miR-144 and miR-34a
    Shaghayegh Pishkari et al, 2021 CrossRef
26. The Regulating Effect of Autophagy-Related MiRNAs in Kidney, Bladder, and Prostate Cancer
    Kai Huang et al, 2021, Journal of Oncology CrossRef
27. The comprehensive landscape of miR-34a in cancer research.
    Sijing Li et al, 2021, Cancer Metastasis Rev CrossRef
28. General Anesthesia and Perioperative Management via microRNA
    Masashi Ishikawa, 2021, Nihon Ika Daigaku Igakkai Zasshi CrossRef
29. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
    Milad Ashrafizadeh et al, 2021, Life Sciences CrossRef
30. LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells
    Lingxi Chen et al, 2021, Front. Cell Dev. Biol. CrossRef
31. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors
    Maria Konoshenko et al, 2021, Andrology CrossRef
32. Targeting Atg4B for cancer therapy: Chemical mediators
    Gaoxia Yang et al, 2021, European Journal of Medicinal Chemistry CrossRef
33. The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
    Danrui Cui et al, 2021, Front. Cell Dev. Biol. CrossRef
34. Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
    Deniz Mortazavi et al, 2022, Journal of Oncology CrossRef
35. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
    Yuhe Lei et al, 2022, Front. Oncol. CrossRef
36. KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter influences the drug resistance to L-OHP
    Caihong Zhang et al, 2022, Aging CrossRef
37. Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
    Milad Ashrafizadeh et al, 2022, J Exp Clin Cancer Res CrossRef
38. AMPK's double-faced role in advanced stages of prostate cancer.
    Faeze Gharibpoor et al, 2022, Clin Transl Oncol CrossRef
39. MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development
    Wen (Jess) Li et al, 2022, Cancers CrossRef
40. The role of the mTOR pathway in diabetic retinopathy
    Fabio Casciano et al, 2022, Front. Med. CrossRef
41. null
    Sandhik Nandi et al, 2023 CrossRef
42. null
    Joanne M. Cosgrave et al, 2023 CrossRef
43. Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
    Marianna Abate et al, 2023, Molecular Therapy - Nucleic Acids CrossRef
44. Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells
    Wenbin Yuan et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
45. Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view
    Pourya Raee et al, 2023, Reprod Biol Endocrinol CrossRef
46. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
    Milad Ashrafizadeh et al, 2024, Cancer Metastasis Rev CrossRef
47. Molecular mechanisms in regulation of autophagy and apoptosis in view of epigenetic regulation of genes and involvement of liquid-liquid phase separation
    Subhajit Chakraborty et al, 2024, Cancer Letters CrossRef